Leading rare disease care for over a decade
Welcome to PANTHERx® Rare Pharmacy, where every day is rare disease day. Serving people living with rare conditions, their families, and care teams is all we do.
Delivered with expertise and empathy
Our continuously improving RxARECARE® model—powered by our SWFT® technology platform—delivers individualized, proactive, and empathetic engagement across the entire patient journey. PANTHERx experts develop deep personal relationships with patients, prescribers, and our manufacturer partners, serving as trusted advocates to ensure seamless collaboration and exceptional care.
Defining rare disease in the U.S.
Over 10,000 rare diseases collectively impact over 30 million people in the U.S.
95% of rare diseases do not currently have an FDA-approved treatment.
Hear the stories behind the numbers from PANTHERx patients.
A pharmacy model built for rare disease
PANTHERx is a dedicated Rare Pharmacy, built around depth, not volume. Rare Pharmacy is not simply a subset of specialty pharmacy. It requires a different ecosystem entirely: journeys are longer, populations are smaller, and every breakdown in care is magnified. Infrastructure that works at scale for chronic, high-volume conditions was not built for rare and cannot adequately adapt.
Differences that make a difference
We understand that quality is not a destination, but a pursuit. While we are honored to consistently earn important industry awards and recognition each year, our teams continue to work each day to raise the bar on quality, speed, and patient-centric innovations to meet the changing demands of the patients, prescribers, and partners we serve.
Accreditations and awards
PANTHERx is licensed in all 50 states and was the first national pharmacy to achieve dual accreditations in rare disease from the Accreditation Commission for Health Care (ACHC) and Utilization Review Accreditation Commission (URAC). PANTHERx is also the nine-time winner of the prestigious MMIT Patient Choice Award for patient satisfaction, including the 2026 honor.
News and Insights
How Fragmentation Delays Rare Disease Therapy Access | Pharmaceutical Commerce
From Hope to Access: Three Lessons From the Front Lines of Rare Disease Launches
By Katie DiLorenzo, PharmD, SVP, Patient and Pharmacy Services and Austin Russian, PharmD, SVP, Program Excellence...
PANTHERx® Rare Pharmacy Earns 2026 MMIT Patient Choice Award for Patient Satisfaction
PITTSBURGH – PANTHERx® Rare, the trusted leader and innovator in patient access and support services for...